PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-32

  1. 830 Posts.
    lightbulb Created with Sketch. 207
    we've all been stooged into to being "classic mugs" it appears so you sure ain't alone on that one mate.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.